Anthem (NYSE:ANTM) issued an update on its FY 2019 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $19.30 for the period.
NYSE ANTM opened at $251.79 on Thursday. Anthem has a fifty-two week low of $227.16 and a fifty-two week high of $317.99. The stock’s 50-day moving average is $269.17 and its two-hundred day moving average is $279.12. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.64 and a quick ratio of 1.64. The firm has a market cap of $66.15 billion, a P/E ratio of 15.85, a price-to-earnings-growth ratio of 0.96 and a beta of 0.74.
Anthem (NYSE:ANTM) last posted its earnings results on Wednesday, July 24th. The company reported $4.64 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.61 by $0.03. Anthem had a return on equity of 15.02% and a net margin of 4.21%. The company had revenue of $25.20 billion for the quarter, compared to analyst estimates of $24.88 billion. During the same period last year, the company earned $4.25 earnings per share. The business’s revenue was up 10.9% compared to the same quarter last year. On average, equities analysts expect that Anthem will post 19.36 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.20 annualized dividend and a yield of 1.27%. Anthem’s dividend payout ratio (DPR) is currently 20.14%.
Several equities research analysts have recently issued reports on the company. Deutsche Bank assumed coverage on Anthem in a research report on Thursday, September 12th. They issued a buy rating on the stock. Wells Fargo & Co reaffirmed a buy rating on shares of Anthem in a research report on Friday, July 26th. Morgan Stanley raised their price target on Anthem from $359.00 to $371.00 and gave the company an overweight rating in a research report on Friday, July 12th. Zacks Investment Research downgraded Anthem from a buy rating to a hold rating and set a $289.00 price target on the stock. in a research report on Monday, August 19th. Finally, ValuEngine downgraded Anthem from a hold rating to a sell rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, two have given a hold rating and fourteen have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $325.93.
In other news, Director Robert L. Dixon, Jr. sold 520 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $294.11, for a total value of $152,937.20. Following the sale, the director now directly owns 9,971 shares of the company’s stock, valued at $2,932,570.81. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.17% of the company’s stock.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Recommended Story: Equal Weight Rating
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.